Compare SBSI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SBSI | CYRX |
|---|---|---|
| Founded | 1960 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 950.3M | 814.9M |
| IPO Year | 1995 | 2008 |
| Metric | SBSI | CYRX |
|---|---|---|
| Price | $30.49 | $17.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $34.33 | $19.33 |
| AVG Volume (30 Days) | 97.1K | ★ 452.6K |
| Earning Date | 10-23-2026 | 11-03-2026 |
| Dividend Yield | ★ 4.92% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ 1.68 | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $4.73 | $10.96 |
| Revenue Next Year | $3.13 | $9.97 |
| P/E Ratio | $18.11 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.32 | $7.61 |
| 52 Week High | $36.20 | $17.98 |
| Indicator | SBSI | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 28.25 | 59.06 |
| Support Level | $30.06 | $14.55 |
| Resistance Level | $33.52 | $17.98 |
| Average True Range (ATR) | 0.62 | 0.51 |
| MACD | -0.12 | 0.03 |
| Stochastic Oscillator | 1.86 | 68.73 |
Southside Bancshares Inc is a bank holding company. Through its subsidiary, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.